UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 21, 2021

 

 

 

JRSIS HEALTH CARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Florida   1-36758   46-4562047
(State or Other Jurisdiction   (Commission   (I.R.S. Employer
of Incorporation)   File Number)   Identification No.)

 

No. 38 South Street, Hulan District, Harbin City

Heilongjiang Province, P.R. China 150025

(Address of Principal Executive Office) (Zip Code)

 

86-451-56888933

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         
         

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events

 

On March 21, 2021 the Registrant issued a press release describing the opening of the Department of Psychiatry at Harbin Jiarun Hospital.

 

Item 9.01 Financial Statements and Exhibits

 

Exhibits

 

99   Press Release dated March 21, 2021 regarding the Harbin Jiarun Hospital Department of Psychiatry.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  JRSIS Health Care Corporation
     

Date: March 21, 2021

By:

/s/ Lihua Sun

    Lihua Sun, Chief Executive Officer

 

2

 

Exhibit 99

 

As the region’s first practice, the Department of Psychiatry of JRSS has been opened for consultation

 

In order to meet the mental health needs of common people, the Department of Psychiatry of JRSS (Harbin Jiarun hospital) was officially opened for consultation. As the region’s first psychiatric specialty, it has filled the gap in this region, opening a brand new chapter in mental and psychological services, and providing scientific, advanced and comprehensive diagnosis and treatment services for mental patients throughout the province.

 

According to the data from the Mental Health Center of the Chinese Center for Disease Control and Prevention, the number of various kinds of mental patients in China has exceeded 100 million, among which 16 million are suffering from severe mental disorders. Such patients live in a “different world”, suffering from mental torture and bringing untold sufferings to their families.

 

 

The Department of Psychiatry of JRSS (Jiarun Hospital), is the region’s first psychiatric specialty. The medical team of the department is provided with strong strength, advanced equipment, complete functions and comfortable environment. The first-class psychiatric experts with rich clinical experience and top professional technical level in the province are engaged, and advanced instruments are equipped.

 

The Department gives full play to the technology-leading and driving role of experts, actively introduces advanced treatment technology in the field of mental diseases, diversifies treatment methods, enhances treatment level, improves disease prognosis, and builds a psychiatric medical highland. Adhering to the concept of whole-course treatment and whole-course rehabilitation, providing family-style therapy and nursing for the majority of mental patients, organically combining treatment, nursing and rehabilitation, the Department aims to jointly create a paradise for the rehabilitation of mental patients.

 

 

 

 

Scope of Diagnosis & Treatment

 

Organic psychosis, alcohol dependence, alcoholism, schizophrenia, neurosis, manic depression, personality disorder, mental retardation, adolescent psychological disorder, emotional disorder, insomnia and other mental diseases.

 

 

About JRSIS Health Care Corporation.

 

JRSIS Health Care Corporation is a corporation organized in the United States under laws of the State of Florida, which owns one main hospital and two branches located in Harbin City in the People’s Republic of China. The Company provides well rounded medical services to all of its patients. From less complicated services such as Dentistry to highly sophisticated operations such as General Surgery, the Hospitals’ staff are prepared to provide immediate medical treatment services throughout all 24 hours of the day. The modern facilities and cutting-edge equipment, as well as highly skilled and experienced personnel, enable the Hospitals to attend to patient medical and healthcare needs. The Company offer comprehensive healthcare services including: medical consulting, surgery, obstetrics and gynecology, pediatrics, anesthesia, clinic laboratory, medical imaging, and traditional Chinese medicine.

 

Contact: 
---------------------------------- 
2860264901@qq.com 

RELATED LINKS

JRSIS Health Care Corporation

http://www.jhcc.cn